Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| rVue Holdings, Inc. | 1,000,000 | reported | 03 Dec 2013 | tx 2+1,500,000 |
| OMNICOM GROUP INC. | 194,984 | reported | 31 Mar 2010 | tx 19+848,136−120,000 |
| AGENUS INC | 122,500 | reported | 24 Apr 2026 | tx 7+177,270 |
| AMX CORP /TX/ | 60,540 | reported | 19 Aug 2004 | tx 1+11,923 |
| Morgans Hotel Group Co. | 41,269 | reported | 17 May 2012 | tx 6+43,875 |
| Advanced Flower Capital Inc. | 24,539 | reported | 20 Nov 2025 | tx 7+20,211 |
| Dipexium Pharmaceuticals, LLC | 20,000 | reported | 17 Jan 2017 | tx 4+55,000 |
| Zynerba Pharmaceuticals, Inc. | 15,000 | reported | 06 Jun 2018 | tx 8+96,495 |
| Acurx Pharmaceuticals, Inc. | 2,150 | reported | 20 Apr 2026 | tx 4+74,150 |
| EPOCRATES INC | 0 | reported | 12 Mar 2013 | tx 11+23,580−128,379 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Apr 2026 | GRANT_AWARD | AGENUS INC | 122,500 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 2,150 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | AGENUS INC | 7,691 | 3.98 USD | |
| 20 Nov 2025 | GRANT_AWARD | Advanced Flower Capital Inc. | 5,474 | 2.74 USD | |
| 01 Oct 2025 | GRANT_AWARD | AGENUS INC | 5,780 | 5.01 USD | |
| 01 Jul 2025 | GRANT_AWARD | AGENUS INC | 7,401 | 3.46 USD | |
| 17 Jun 2025 | GRANT_AWARD | AGENUS INC | 17,500 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | AGENUS INC | 8,898 | 2.88 USD | |
| 25 Feb 2025 | GRANT_AWARD | Advanced Flower Capital Inc. | 1,792 | 8.37 USD | |
| 07 Aug 2024 | GRANT_AWARD | AGENUS INC | 7,500 | 0.00 USD | deriv |
| 17 Jun 2024 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 24 Jan 2024 | GRANT_AWARD | Advanced Flower Capital Inc. | 1,282 | 11.70 USD | |
| 15 Jun 2023 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Advanced Flower Capital Inc. | 963 | 15.57 USD | |
| 11 Jan 2022 | GRANT_AWARD | Advanced Flower Capital Inc. | 5,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Acurx Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 23 Mar 2021 | PURCHASE | Advanced Flower Capital Inc. | 5,000 | 19.00 USD | first after silence |
| 23 Mar 2021 | GRANT_AWARD | Advanced Flower Capital Inc. | 700 | 0.00 USD | deriv |
| 06 Jun 2018 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 15,000 | 0.00 USD | deriv |
| 08 Dec 2017 | SALE | Fifth Street Asset Management Inc. | 6,000 | 4.05 USD | |
| 30 Nov 2017 | SALE | Fifth Street Asset Management Inc. | 20,000 | 4.07 USD | |
| 30 Nov 2017 | EXERCISE | Fifth Street Asset Management Inc. | 20,000 | 3.28 USD | |
| 30 Nov 2017 | EXERCISE | Fifth Street Asset Management Inc. | 20,000 | 0.00 USD | deriv |
| 02 Oct 2017 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 2,057 | 5.47 USD | deriv |
| 03 Jul 2017 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 1,058 | 10.63 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 23 Mar 2021.